By proceeding, you agree to our Terms of Use and Privacy Policy.
Group leader with experience creating and enabling high performing, decision-driven, cross-functional teams to support the development of novel therapies to treat Type 2 diabetes and its associated complications.
Talks About #biology #Diabetesdiscovery
Preferred Locations #NorthAmerica
Welcome to the 6th Obesity & NASH Drug Development Summit There has been a rise and fall of investment in NASH in the wake of highly demanding biopsy endpoints and late-stage clinical setbacks.
